Rationale: Suboptimal vaccine immunogenicity and antigenic mismatch, compounded by poor uptake, means that influenza remains a major global disease. T cells recognizing peptides derived from conserved viral proteins could enhance vaccine-induced cross-strain protection. Objectives: To investigate the kinetics, phenotypes, and function of influenza virus-specific CD8+ resident memory T (Trm) cells in the lower airway and infer the molecular pathways associated with their response to infection in vivo. Methods: Healthy volunteers, aged 18-55, were inoculated intranasally with influenza A/California/4/09(H1N1). Blood, upper airway, and (in a subgroup) lower airway samples were obtained throughout infection. Symptoms were assessed by using self-reported diaries, and the nasal viral load was assessed by using quantitative PCR. T-cell responses were analyzed by using a three-color FluoroSpot assay, flow cytometry with MHC I-peptide tetramers, and RNA sequencing, with candidate markers being confirmed by using the immunohistochemistry results for endobronchial biopsy specimens. Measurements and Main Results: After challenge, 57% of participants became infected. Preexisting influenza-specific CD8+ T cells in blood correlated strongly with a reduced viral load, which peaked at Day 3. Influenza-specific CD8+ T cells in BAL fluid were highly enriched and predominantly expressed the Trm markers CD69 and CD103. Comparison between preinfection CD8+ T cells in BAL fluid and blood by using RNA sequencing revealed 3,928 differentially expressed genes, including all major Trm-cell markers. However, gene set enrichment analysis of BAL-fluid CD8+ T cells showed primarily innate cell-related pathways and, during infection, included upregulation of innate chemokines (Cxcl1, Cxcl10, and Cxcl16) that were also expressed by CD8+ cells in bronchial tissues. Conclusions: CD8+ Trm cells in the human lung display innate-like gene and protein expression that demonstrates blurred divisions between innate and adaptive immunity. Clinical study registered with www.clinicaltrials.gov (NCT02755948).
Rationale: Suboptimal vaccine immunogenicity and antigenic mismatch, compounded by poor uptake, means that influenza remains a major global disease. T cells recognizing peptides derived from conserved viral proteins could enhance vaccine-induced cross-strain protection. Objectives: To investigate the kinetics, phenotypes, and function of influenza virus-specific CD8+ resident memory T (Trm) cells in the lower airway and infer the molecular pathways associated with their response to infection in vivo. Methods: Healthy volunteers, aged 18-55, were inoculated intranasally with influenza A/California/4/09(H1N1). Blood, upper airway, and (in a subgroup) lower airway samples were obtained throughout infection. Symptoms were assessed by using self-reported diaries, and the nasal viral load was assessed by using quantitative PCR. T-cell responses were analyzed by using a three-color FluoroSpot assay, flow cytometry with MHC I-peptide tetramers, and RNA sequencing, with candidate markers being confirmed by using the immunohistochemistry results for endobronchial biopsy specimens. Measurements and Main Results: After challenge, 57% of participants became infected. Preexisting influenza-specific CD8+ T cells in blood correlated strongly with a reduced viral load, which peaked at Day 3. Influenza-specific CD8+ T cells in BAL fluid were highly enriched and predominantly expressed the Trm markers CD69 and CD103. Comparison between preinfection CD8+ T cells in BAL fluid and blood by using RNA sequencing revealed 3,928 differentially expressed genes, including all major Trm-cell markers. However, gene set enrichment analysis of BAL-fluid CD8+ T cells showed primarily innate cell-related pathways and, during infection, included upregulation of innate chemokines (Cxcl1, Cxcl10, and Cxcl16) that were also expressed by CD8+ cells in bronchial tissues. Conclusions: CD8+ Trm cells in the human lung display innate-like gene and protein expression that demonstrates blurred divisions between innate and adaptive immunity. Clinical study registered with www.clinicaltrials.gov (NCT02755948).
Entities:
Keywords:
CD8+ T cell; controlled human infection; influenza; resident memory
Authors: Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley Journal: J Leukoc Biol Date: 2013-09-04 Impact factor: 4.962
Authors: Lin Lin; Greg Finak; Kevin Ushey; Chetan Seshadri; Thomas R Hawn; Nicole Frahm; Thomas J Scriba; Hassan Mahomed; Willem Hanekom; Pierre-Alexandre Bart; Giuseppe Pantaleo; Georgia D Tomaras; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Nelson L Michael; Jerome H Kim; Merlin L Robb; Robert J O'Connell; Nicos Karasavvas; Peter Gilbert; Stephen C De Rosa; M Juliana McElrath; Raphael Gottardo Journal: Nat Biotechnol Date: 2015-05-25 Impact factor: 54.908
Authors: R G Pebody; F Warburton; J Ellis; N Andrews; C Thompson; B von Wissmann; H K Green; S Cottrell; J Johnston; S de Lusignan; C Moore; R Gunson; C Robertson; J McMenamin; M Zambon Journal: Euro Surveill Date: 2015-02-05
Authors: Timothy S C Hinks; Xiaoying Zhou; Karl J Staples; Borislav D Dimitrov; Alexander Manta; Tanya Petrossian; Pek Y Lum; Caroline G Smith; Jon A Ward; Peter H Howarth; Andrew F Walls; Stephan D Gadola; Ratko Djukanović Journal: J Allergy Clin Immunol Date: 2015-03-05 Impact factor: 10.793
Authors: Jun Siong Low; Yagmur Farsakoglu; Maria Carolina Amezcua Vesely; Esen Sefik; Joseph B Kelly; Christian C D Harman; Ruaidhri Jackson; Justin A Shyer; Xiaodong Jiang; Linda S Cauley; Richard A Flavell; Susan M Kaech Journal: J Exp Med Date: 2020-08-03 Impact factor: 14.307
Authors: Bonnie van Wilgenburg; Liyen Loh; Zhenjun Chen; Troi J Pediongco; Huimeng Wang; Mai Shi; Zhe Zhao; Marios Koutsakos; Simone Nüssing; Sneha Sant; Zhongfang Wang; Criselle D'Souza; Xiaoxiao Jia; Catarina F Almeida; Lyudmila Kostenko; Sidonia B G Eckle; Bronwyn S Meehan; Axel Kallies; Dale I Godfrey; Patrick C Reading; Alexandra J Corbett; James McCluskey; Paul Klenerman; Katherine Kedzierska; Timothy S C Hinks Journal: Nat Commun Date: 2018-11-09 Impact factor: 14.919
Authors: Sean R McMaster; Alexander N Wein; Paul R Dunbar; Sarah L Hayward; Emily K Cartwright; Timothy L Denning; Jacob E Kohlmeier Journal: Mucosal Immunol Date: 2018-02-16 Impact factor: 7.313
Authors: Rod A Rahimi; Josalyn L Cho; Claudia V Jakubzick; Shabaana A Khader; Bart N Lambrecht; Clare M Lloyd; Ari B Molofsky; Sebastien Talbot; Catherine A Bonham; Wonder P Drake; Anne I Sperling; Benjamin D Singer Journal: Am J Respir Cell Mol Biol Date: 2022-07 Impact factor: 7.748
Authors: Ben Killingley; Alex J Mann; Mariya Kalinova; Alison Boyers; Niluka Goonawardane; Jie Zhou; Kate Lindsell; Samanjit S Hare; Jonathan Brown; Rebecca Frise; Emma Smith; Claire Hopkins; Nicolas Noulin; Brandon Löndt; Tom Wilkinson; Stephen Harden; Helen McShane; Mark Baillet; Anthony Gilbert; Michael Jacobs; Christine Charman; Priya Mande; Jonathan S Nguyen-Van-Tam; Malcolm G Semple; Robert C Read; Neil M Ferguson; Peter J Openshaw; Garth Rapeport; Wendy S Barclay; Andrew P Catchpole; Christopher Chiu Journal: Nat Med Date: 2022-03-31 Impact factor: 87.241